The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Much Growth In Market Value Is Expected For The Automated Compounding Devices Market Between 2026 And 2030?
The automated compounding devices market has experienced robust expansion in recent years. It is projected to increase from $2.51 billion in 2025 to $2.69 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 7.1%. This historical growth can be attributed to several factors, including an escalating hospital pharmacy workload, a rising demand for sterile IV preparation, the early adoption of TPN compounding automation, hospital initiatives aimed at reducing compounding errors, and the expansion of inpatient medication therapy volumes.
The market for automated compounding devices is projected to experience substantial expansion in the coming years. This sector is anticipated to reach a valuation of $3.53 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.0%. The growth during this forecast period can be primarily attributed to a heightened focus on medication safety compliance, increased capital allocation towards automated pharmacy technologies, a rise in the outsourcing of sterile compounding operations, the broadening scope of drug compounding for oncology and critical care, and the expanded incorporation of digital workflow and reporting platforms. Key trends expected over the forecast horizon include the wider uptake of automated compounding devices aimed at minimizing errors in manual medication preparation within hospitals and pharmacies, an escalating need for highly precise compounding of IV formulations, oncology medications, and TPN solutions, a developing move towards centralized and high-volume sterile compounding facilities within healthcare systems, the increased application of automated workflow validation and barcode verification in compounding processes, and a growing inclination towards compact, modular, and upgradeable automated compounding platforms for pharmacy use.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18231&type=smp
Which Key Drivers Are Affecting The Automated Compounding Devices Market Development?
The expansion in personalized medical treatments is projected to propel the automated compounding devices market forward. Personalized medicine describes a healthcare strategy where decisions, practices, and treatments are customized to each patient’s unique attributes. This rise in personalized medicines stems from enhanced genetic understanding, patient-specific data analysis, and supportive regulations. Automated compounding devices (ACDs) are vital in personalized medicine, facilitating the precise creation of custom drug formulations for specific patient requirements. These devices automate the blending of pharmaceutical components in exact ratios, which is fundamental for developing individualized therapies. As an illustration, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, reported that the FDA sanctioned 16 new personalized treatments for rare diseases in 2023, up from six in 2022. Consequently, the growing volume of personalized medicines is boosting the automated compounding devices market’s expansion.
Which Segments Define The Automated Compounding Devices Market Segment Structure?
The automated compounding devices market covered in this report is segmented –
1) By Component: Automated Compounding Systems Equipment, Automated Compounding Systems Software
2) By Product Type: Intravenous Compounding Systems, Oral Compounding Systems, Total Parenteral Nutrition (TPN) Compounding Systems
3) By Mode Of Operation: Fully Automated Compounding Systems, Semi-Automated Compounding Systems
4) By End-User: Hospitals, Ambulatory Surgical Centers, Other End Users
Subsegments:
1) By Automated Compounding Systems Equipment: Compounding Workstations, Compounding Pumps, Mixing Chambers, Scales And Balances, Dispensing Units, Vial And Syringe Filling Systems, Other Related Equipment (Filtration Devices)
2) By Automated Compounding Systems Software: Prescription Management Software, Workflow Management Software, Monitoring And Control Software, Data Analytics And Reporting Software, Safety And Compliance Software, Integration Software For Hospital Or Pharmacy Management Systems
What Trends Are Transforming The Automated Compounding Devices Market?
Major companies operating in the automated compounding devices market are focusing on AI-powered robotic compounding, such as AI-enabled IV compounding platform systems. These systems leverage artificial intelligence, gravimetric verification, and cloud-based monitoring to automate sterile admixture preparation with high precision, real-time quality checks, and continuous oversight. For instance, in August 2025, Omnicell, a US-based health-technology company, unveiled an AI-enhanced upgrade to its IV compounding system designed to bolster safety and accuracy in medication preparation. The updated system integrates advanced AI-based quality-assurance tools that continuously monitor compounding activities, automatically detecting and flagging any deviations from expected procedures. Through the introduction of this automated oversight, Omnicell aims to reduce human error, improve workflow efficiency, and support higher standards of medication quality in pharmacy operations.
Who Are The Established Players Within The Automated Compounding Devices Market?
Major companies operating in the automated compounding devices market are Becton Dickinson and Company, Baxter International Inc, B Braun Melsungen AG, Fresenius Kabi AG, Terumo Corporation, ICU Medical Inc., Omnicell Inc., Tecan Group Ltd., Fagron NV, Swisslog Healthcare, ScriptPro LLC, PharMEDium Services LLC, Loccioni Group SPA, ARxIUM Inc., Codonics Inc., Equashield LLC, Yuyama Mfg Co Ltd, Shanghai Weibond Technology Co Ltd, Medimpex LLC, Medica Inc
Get The Full Automated Compounding Devices Market Report:
https://www.thebusinessresearchcompany.com/report/automated-compounding-devices-global-market-report
Where Is The Automated Compounding Devices Market Primarily Concentrated By Region?
North America was the largest region in the automated compounding devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the automated compounding devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Automated Compounding Devices Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/customise?id=18231&type=smp
Browse Through More Reports Similar to the Global Automated Compounding Devices Market 2026, By The Business Research Company
Plastic Compounding Market Report 2026
https://www.thebusinessresearchcompany.com/report/plastic-compounding-global-market-report
Compound Management Market Report 2026
https://www.thebusinessresearchcompany.com/report/compound-management-global-market-report
Electronic Products Market 2026
https://www.thebusinessresearchcompany.com/report/electronic-products-market
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model